VAXIL Introduction – Cancer Immunotherapy Posted on July 11, 2016July 28, 2016 by David Goren 11 Jul Vaxil is an Israeli cancer research biotech, focused on innovative & targeted immuno-oncology treatments Immunotherapies harness the body’s own immune system to recognize and target cancer Vaxil Receives Positive Response From European Patent Office for the Allowance of the Immunotherapy Orphan Drug Designated ImMucin™ VAXIL ANNOUNCES KEY US PATENT AND TRADEMARK OFFICE NOTICE OF ALLOWANCE FOR ITS IMMUNOTHERAPY